logo

For the Inventor, By the Inventor

Basel, Switzerland

Hans Kuhnis

USPTO Granted Patents = 9

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 53(Granted Patents)


Company Filing History:

goldMedal9 out of 6,850 
 
Ciba-geigy Corporation
 patents

Years Active: 1977-1989

Loading Chart...
9 patents (USPTO):Explore Patents
1. 4808603 - 3,5-diacyl-2,6-dialkyl-4-aryl-1,4-dihydropyridines, their use, and (1989-02-28),
2. 4616002 - Dihydro pyridine compounds, compositions and use (1986-10-07),
3. 4497808 - N-Oxide compounds useful in the treatment of cardiovascular ailments (1985-02-05),
4. 4304912 - Piperidine derivatives (1981-12-08),
5. 4264599 - Piperidino-propanols (1981-04-28),
6. 4217350 - Oxygenated N-aryl-diazacyclic compounds (1980-08-12),
7. 4144344 - Antihypertensive 1-substituted-4-(2-oxo-1-imidazolidinyl) piperidines (1979-03-13),
8. 4029795 - 4(2' Isoquinolin-1-one)piperidines (1977-06-14),
9. 4017629 - Certain 1,4-dihydro-3-sulfinyl or sulfonyl-pyridines (1977-04-12),

Title: Innovations of Hans Kuhnis

Introduction

Hans Kuhnis is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of compounds with cardiovascular properties. With a total of 9 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

Kuhnis's latest patents include innovative compounds such as 3,5-diacyl-2,6-dialkyl-4-aryl-1,4-dihydropyridines. These compounds are recognized for their use in treating cardiovascular conditions, especially for their coronary dilatory and anti-hypertensive properties. Another significant patent involves dihydro pyridine compounds that exhibit blood pressure-reducing properties, showcasing his focus on improving cardiovascular health.

Career Highlights

Throughout his career, Hans Kuhnis has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work has not only advanced scientific understanding but has also contributed to the development of effective treatments for heart-related ailments.

Collaborations

Kuhnis has collaborated with esteemed colleagues such as Kurt Eichenberger and Franz Ostermayer. These partnerships have fostered a collaborative environment that has led to innovative breakthroughs in their field.

Conclusion

Hans Kuhnis's contributions to the field of chemistry and cardiovascular health are noteworthy. His patents reflect a commitment to advancing medical science and improving patient outcomes. His work continues to inspire future innovations in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…